G01N 2333/8139
Cysteine protease inhibitors
Official title: Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
G01N2333/8139 (Cysteine protease inhibitors) appears on 37 US grants and 104 published applications in this corpus.
Search patents in G01N- Granted patents
- 37
- Published applications
- 104
- Assignees
- 70
- Inventors
- 237
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 2 |
| 2003 | 0 | 2 |
| 2004 | 2 | 4 |
| 2005 | 0 | 0 |
| 2006 | 1 | 4 |
| 2007 | 0 | 1 |
| 2008 | 1 | 4 |
| 2009 | 2 | 2 |
| 2010 | 1 | 2 |
| 2011 | 1 | 14 |
| 2012 | 3 | 1 |
| 2013 | 0 | 1 |
| 2014 | 4 | 6 |
| 2015 | 1 | 13 |
| 2016 | 1 | 5 |
| 2017 | 2 | 6 |
| 2018 | 2 | 5 |
| 2019 | 1 | 3 |
| 2020 | 2 | 6 |
| 2021 | 1 | 3 |
| 2022 | 1 | 3 |
| 2023 | 2 | 3 |
| 2024 | 2 | 6 |
| 2025 | 2 | 5 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for differentiating progressive chronic kidney disease from stable chronic kidney disease19 May 2026US 12,631,655 B2IDEXX Laboratories, Inc.
- Methods for determining the concentration of an analyte in the plasma fraction of a sample of whole blood17 Mar 2026US 12,578,330 B2Gentian AS
- Methods and compositions for the detection and diagnosis of renal disease and periodontal disease12 Aug 2025US 12,385,927 B2IDEXX Laboratories, Inc.
- Method of determining risk of an adverse cardiac event15 Jul 2025US 12,360,115 B2McMaster University
- Diagnosis and treatment of autoimmune diseases13 Aug 2024US 12,061,206 B2Takeda Pharmaceutical Company Limited
- Peptide substrates and inhibitors of cathepsin b10 Sep 2026US 2026/0265298 A1The Regents of the University of California
- Dll1 marker panels for early detection of sepsis3 Sep 2026US 2026/0259226 A1Roche Diagnostics Operations, Inc.
- Biomarkers8 Jan 2026US 2026/0009802 A1Oxford University Innovation Limited
- Nasal cavity sampling methods and apparatus18 Dec 2025US 2025/0381353 A1Rocket Science Health Corp.
- Methods and compositions for the detection and diagnosis of renal disease and periodontal disease6 Nov 2025US 2025/0341529 A1IDEXX Laboratories, Inc.
Most cited
By later US patents
- Compounds and methods to enhance rAAV transduction30US 8,846,030 B2University of Iowa Research Foundation · 2014
- Modulation of the neuroendoctrine system as a therapy for motor neuron disease26US 7,572,596 B2University of Pittsburgh—Of the Commonwealth System of Higher Education · 2009
- Method of diagnosing Alzheimer's disease20US 6,130,048 AThe McLean Hospital Corporation · 2000
- Atypical hemolytic uremic syndrome (AHUS) biomarker proteins11US 9,494,601 B2Alexion Pharmaceuticals, Inc. · 2016
- Atypical hemolytic uremic syndrome (aHUS) biomarker proteins8US 9,658,236 B2Alexion Pharmaceuticals, Inc. · 2017